GLP-1 & GIP Double Action Weight Loss: Tirzepatide

Tirzepatide is a dual GLP-1/GIP receptor agonist, a medication that mimics two gut hormones tied to appetite, insulin response, and blood sugar. It's the active ingredient behind the FDA-approved medications Mounjaro (type 2 diabetes) and Zepbound (chronic weight management). The version Mankind Health provides is a separate compounded formulation, not Mounjaro or Zepbound themselves, your provider can explain the difference.

Semaglutide works primarily through GLP-1 signaling. Tirzepatide works through both GLP-1 and GIP pathways, which may provide broader metabolic and appetite-support signaling for some patients.

That depends on your health history, current medications, and goals, which a licensed Mankind Health provider reviews during your consultation, this page can't make that call. Like other GLP-1/GIP medications, it carries specific precautions, including for anyone with a personal or family history of certain thyroid cancers, and it isn't right for everyone.

No extreme dieting is required. The goal is a sustainable calorie deficit with enough protein, fiber, and resistance training to protect muscle, support digestion, and keep results looking athletic. We generally recommend at least 1 gram of protein per pound of goal body weight per day for women, with many working up toward 1.5 grams per pound when appropriate. For men, pushing closer to 2 grams per pound of goal body weight can be even better for supporting lean muscle, satiety, and body composition. Adding fiber supplementation can help support digestion and regularity, and resistance training should be part of the plan to help preserve muscle while fat loss progresses.

Yes. Many patients use Tirzepatide alongside optimized hormones like TRT or HRT. Hormones may support energy, training, recovery, and consistency, while Tirzepatide helps with appetite control and adherence. Your provider will confirm the safest approach based on your labs and goals.